MEDP
Medpace Holdings, Inc.
Stock
$599.47+1.39 (+0.23%)Close Oct 2, 2026
Income statement
| Line | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.8B | $2.5B | $2.1B | $1.9B | $1.5B | $1.1B | $926M | $861M | $705M | $436M | $422M | $359M |
| SG&A | $189M | $198M | $180M | $161M | $131M | $108M | $92M | $95M | $76M | $63M | $62M | $57M |
| Operating income | $583M | $535M | $447M | $337M | $279M | $199M | $167M | $127M | $101M | $65M | $52M | $21M |
| Non-operating income | $16M | $7.4M | $29M | −$1.1M | $4.2M | $3.2M | $1.5M | −$2.4M | −$7.1M | −$7.9M | −$31M | −$28M |
| Pretax income | $599M | $542M | $476M | $336M | $283M | $202M | $169M | $125M | $94M | $57M | $22M | −$7.8M |
| Taxes | $107M | $91M | $72M | $53M | $37M | $20M | $23M | $24M | $21M | $18M | $8.5M | $843K |
| Net income | $492M | $451M | $404M | $283M | $245M | $182M | $145M | $100M | $73M | $39M | $13M | −$8.7M |
| Diluted EPS | $17.06 | $15.28 | $12.63 | $8.88 | $7.28 | $4.81 | $3.84 | $2.67 | $1.97 | $0.98 | $0.37 | −$0.28 |
| Diluted shares | — | 29.5M | 32.0M | 31.8M | 33.7M | 37.7M | 37.7M | 37.6M | 36.9M | 39.8M | 36.3M | 31.3M |
| Revenue growth | — | +20.0% | +11.8% | +29.2% | +27.8% | +23.4% | +7.5% | +22.2% | +61.5% | +3.5% | +17.4% | — |
| Operating margin | 21.0% | 21.1% | 21.2% | 17.9% | 19.1% | 17.4% | 18.0% | 14.8% | 14.3% | 14.9% | 12.5% | 5.7% |
| Net margin | 17.7% | 17.8% | 19.2% | 15.0% | 16.8% | 15.9% | 15.7% | 11.7% | 10.4% | 9.0% | 3.2% | −2.4% |